Literature DB >> 23263439

[Update on gynecopathology].

D Schmidt1.   

Abstract

Recent years have witnessed significant achievements in light microscopic, immunohistochemical and molecular diagnostics in gynecopathology. In this article four topics will be discussed as examples. The squamous precancerous and carcinomatous lesions of the female anogenital tract and the cervix are caused by a transforming high risk human papillomavirus (HPV) infection. No differences in morphological findings can be found between the different locations. In contrast to the current WHO classification a new categorization into low grade and high grade precancerous lesions is suggested. Only some cervical adenocarcinomas are related to high risk HPV infection. Nevertheless, some of these unusual variants demonstrate p16 overexpression. Uterine leiomyosarcomas are clinically aggressive neoplasms independent of the histological grade and in most cases curative treatment is not feasible. It is most important to distinguish leiomyosarcoma from those leiomyoma variants which mimic uterine leiomyosarcoma. Pelvic and ovarian serous carcinomas can be separated into low grade and high grade types which differ significantly in formal pathogenesis, molecular features and pathomorphological findings. Significant differences are also obvious in clinical behavior and response to chemotherapy regimens.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23263439     DOI: 10.1007/s00292-012-1705-6

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  37 in total

1.  p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.

Authors:  Lars-Christian Horn; Kristin Lindner; Grit Szepankiewicz; Jeanett Edelmann; Bettina Hentschel; Andrea Tannapfel; Karl Bilek; Uwe-Gerd Liebert; Cristine E Richter; Jens Einenkel; Cornelia Leo
Journal:  Int J Gynecol Pathol       Date:  2006-04       Impact factor: 2.762

2.  An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.

Authors:  Ciaran J O'Neill; Michael T Deavers; Anais Malpica; Heather Foster; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2005-08       Impact factor: 6.394

3.  Patterns of low-grade serous carcinoma with emphasis on the nonepithelial-lined spaces pattern of invasion and the disorganized orphan papillae.

Authors:  Elvio G Silva; Michael T Deavers; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2010-11       Impact factor: 2.762

4.  MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.

Authors:  Dominique Nadine Markowski; Sabine Bartnitzke; Thomas Löning; Norbert Drieschner; Burkhard Maria Helmke; Jörn Bullerdiek
Journal:  Int J Cancer       Date:  2012-02-28       Impact factor: 7.396

5.  Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.

Authors:  S W Bell; R L Kempson; M R Hendrickson
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

6.  Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors.

Authors:  Longwen Chen; Bin Yang
Journal:  Int J Gynecol Pathol       Date:  2008-07       Impact factor: 2.762

7.  The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.

Authors:  Teresa M Darragh; Terence J Colgan; J Thomas Cox; Debra S Heller; Michael R Henry; Ronald D Luff; Timothy McCalmont; Ritu Nayar; Joel M Palefsky; Mark H Stoler; Edward J Wilkinson; Richard J Zaino; David C Wilbur
Journal:  Int J Gynecol Pathol       Date:  2013-01       Impact factor: 2.762

8.  Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression.

Authors:  B Yang; W R Hart
Journal:  Am J Surg Pathol       Date:  2000-03       Impact factor: 6.394

9.  Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.

Authors:  F J Major; J A Blessing; S G Silverberg; C P Morrow; W T Creasman; J L Currie; E Yordan; M F Brady
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

10.  Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.

Authors:  R Scott Rushing; Shahin Shajahan; Damodaran Chendil; James L Wilder; Joseph Pulliam; Eun Y Lee; Frederick R Ueland; John R van Nagell; Mansoor M Ahmed; Subodh M Lele
Journal:  Gynecol Oncol       Date:  2003-10       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.